Lenvatinib‐associated hemoperitoneum in a patient with primary angiosarcoma of the breast-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenvatinib‐associated hemoperitoneum in a patient with primary angiosarcoma of the breast

Published:2024-03-28 Issue:4 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Orabueze Ijeoma¹^ORCID,Akpan Inemesit²,Denley Ryan³

Affiliation:

1. Department of Internal Medicine Vassar Brothers Medical Center Poughkeepsie New York USA

2. Department of Internal Medicine Piedmont Health Athens Georgia USA

3. Department of Hematology/Oncology Vassar Brothers Medical Center Poughkeepsie New York USA

Abstract

Key Clinical MessageWe highlight the risk of lenvatinib drug toxicity when high‐risk anatomic regions are affected by angiosarcoma.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8701

Reference11 articles.

1. Angiosarcoma: clinical and imaging features from head to toe

2. Lenvatinib

3. A case of multiple intratumoral hemorrhage and rupture of hepatocellular carcinoma after starting lenvatinib;Ishihara K;Case Reports Hepatol,2020

4. Hepatic angiosarcoma manifested as recurrent hemoperitoneum

5. John Hopkins University.Angiosarcoma of the Breast [Internet].2021Accessed February 13 2024.https://www.hopkinsmedicine.org/health/conditions‐and‐diseases/breast‐cancer/angiosarcoma‐of‐the‐breast

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP